Dura Pharmaceuticals, Inc. v. Broudo

543 U.S. 1134, 160 L. Ed. 2d 1092, 125 S. Ct. 1240, 73 U.S.L.W. 3492, 2005 U.S. LEXIS 1388, 2005 WL 387579

Procedural entryThis page is a short order in Dura Pharmaceuticals, Inc. v. Broudo. Read the opinion of the Court — 544 U.S. 336 →

Supreme Court of the United States·Decided February 18, 2005·No. 03-932·Published

Opinion

C. A. 9th Cir. [Certiorari granted, 542 U. S. 936.] Mo *1135 tion of petitioners for leave to file supplemental brief after argument granted.

Free access — add to your briefcase to read the full text and ask questions with AI

Dura Pharmaceuticals, Inc. v. Broudo, 543 U.S. 1134, 160 L. Ed. 2d 1092, 125 S. Ct. 1240, 73 U.S.L.W. 3492, 2005 U.S. LEXIS 1388, 2005 WL 387579 (2005).

Pincite

543 U.S. 1134 (Dura Pharmaceuticals, Inc. v. Broudo) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.